Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease

Kohli, Utkarsh; von Alvensleben, Johannes; Srinivasan, Chandra

doi:10.1016/j.ccep.2023.09.002

Cardiac Electrophysiology Clinics

2023

DOI: 10.1016/j.ccep.2023.09.002

|View full text |Cite

Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease

Utkarsh Kohli,

Johannes von Alvensleben,

Chandra Srinivasan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 106 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, body image concerns were the highest in the lowest BMI group (BMI < 25) and the youngest (age < 50 years). In contrast, previous reviews with subcutaneous ICDs (S‐ICD) in pediatric populations 4 has suggested only minor implant modifications may need to be considered, and Vincentini et al did not find any differences in device acceptance by body habitus 5 …”

mentioning

confidence: 89%

Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)

Sears,

Harrell,

Crozier

et al. 2024

Cardiovasc electrophysiol

View full text Add to dashboard Cite

The subscale of Device-Related Distress directly queries feelings of disfigurement from the device and this may account for the differences.Finally, the question was raised of selection bias related to the possibility of patients at risk for decreased QOL or patients with smaller body habitus leading to possible avoidance of being enrolled in this study. We do not have any data to refute or accept this limitation as this is the initial sample of patients considering EV-ICDs.However, as noted in the paper, 3 we do acknowledge that the process of agreeing to a novel device may induce a degree of positive acceptance bias in patients and in their reporting of outcomes. As a result, we indicated that cautious interpretation of this data is needed until full randomized studies could disentangle these common psychological processes.

show abstract

mentioning

confidence: 89%

Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)

Sears,

Harrell,

Crozier

et al. 2024

Cardiovasc electrophysiol

View full text Add to dashboard Cite

show abstract

Recent Advancements in Cardiac Implantable Devices for Pediatric Patients

Kumthekar,

Howard

2024

Curr Pediatr Rep

View full text Add to dashboard Cite

Purpose of Review We highlight recent advances in cardiac implantable electronic devices (CIEDs) that are applicable and can be beneficial for pediatric patients. Recent Findings Progress in pacemakers includes the widespread use of leadless pacemakers, development of tools for left bundle area pacing, and the design of novel miniaturized pacemakers and minimally invasive approaches for epicardial device implantation. For implantable cardioverter defibrillators (ICDs), there has been more utilization of the subcutaneous ICD in smaller patients or those with congenital heart disease, and significant improvements in ICD programming as well. Summary Leadless pacemakers have been safely utilized in children, even those under 30 kg with acute and medium-term success. Left bundle area pacing may provide a reduction in pacing-induced cardiomyopathy in the future. Novel miniature pacemakers and approaches to epicardial lead implantation can reduce complications for our smallest patients. Subcutaneous ICDs have been used effectively in the pediatric cohort with similar results to the adult population. ICD programming has been improved to reduce the risk of inappropriate shocks.

show abstract

Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?

Dijkshoorn,

Smeding,

Pepplinkhuizen

et al. 2024

Heart Rhythm

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease

Cited by 3 publications

References 106 publications

Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)

Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)

Recent Advancements in Cardiac Implantable Devices for Pediatric Patients

Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?

Contact Info

Product

Resources

About